Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

ACRSACRS
Showing 8 of 31 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in ACLARIS THERAPEUTICS INC

DEUTSCHE BANK AG\ holds 1M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $5.5M as of 2026-Q2. The position was increased (+4.3% shares). ACRS represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$5.5M

Current Shares

1M

Total Value Change

+$4.4M

Total Shares Change

+117,642

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+4.3%
$5.5M0.0%$5.29
28
2026-Q1
Increased
997,850
+1.1%
$3.7M0.0%$3.04
27
2025-Q4
Increased
987,351
+6.9%
$3M0.0%$2.90
28
2025-Q3
Decreased
923,313
-8.3%
$1.8M0.0%$1.92
0
2025-Q2
Increased
1M
+9.0%
$1.4M0.0%$1.47
28
2025-Q1
Unchanged
923,313
0.0%
$1.4M0.0%$1.59
0
2024-Q4
Unchanged
923,313
0.0%
$2.3M0.0%$2.48
0
2024-Q3
Unchanged
923,313
0.0%
$1.1M0.0%$1.17
0

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used